Prescription Drug and Health Improvement Act of 2017
Latest action · Feb 9, 2017 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 9, 2017
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Prescription Drug and Health Improvement Act of 2017
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate lower prices on behalf of Medicare and Medicare Advantage (MA) beneficiaries for covered prescription drugs that the CMS deems appropriate for negotiation based on: (1) program and per-beneficiary spending, (2) unit price increases over the preceding years, (3) initial launch price, (4) availability of similarly effective alternative treatments, (5) status of the drug as a follow-on to previously approved drugs, and (6) any other criteria determined by the CMS.
If, after a one year period, negotiations with respect to a covered prescription drug prove unsuccessful, the CMS shall establish a price for the drug that is equal to the lesser of the price paid by the Department of Veterans Affairs or the price paid by the four largest federal pharmaceutical-drug purchasers.
The CMS may (but is not required to) negotiate lower prices on behalf of Medicare and MA beneficiaries for other covered prescription drugs.
The Government Accountability Office must report to Congress on the CMS' negotiations.
The Center for Medicare and Medicaid Innovation must test several specified models for negotiating drug and biological prices.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Feb 9, 2017 to Mar 29, 2017; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-RI | Jack Reed | Original | Feb 9, 2017 |
| D-OH | Sherrod Brown | Original | Feb 9, 2017 |
| D-NY | Kirsten E. Gillibrand | Mar 29, 2017 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Feb 9, 2017 |
Actions 2
Everything that happened, newest first.
- Feb 9, 2017Introduced in Senate
- Feb 9, 2017Read twice and referred to the Committee on Finance.
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 771 | Improving Access To Affordable Prescription Drugs Act | Related bill | Mar 29, 2017 |
| S 1688 | Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 | Related bill | Aug 1, 2017 |
| HR 1776 | Improving Access To Affordable Prescription Drugs Act | Related bill | Apr 5, 2017 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries.
- Short Titles as Introduced
- Prescription Drug and Health Improvement Act of 2017
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 9, 2017Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
